Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006992 · ClinicalTrials.gov registry record · NA
Growth of Infants Fed Hydrolysate Formulas
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT02006992: Completed NA study, sponsored by Abbott Nutrition.
NCT02006992 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 195 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02006992, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
Effects on weight and weight gain will be monitored in healthy term infants fed assigned infant formulas.
Interventions
- OTHER RTF Infant Formula
- OTHER Powder Infant Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2000-03 |
| Est. Completion | 2000-11 |
| Phase | NA |
What the finished NCT02006992 record still lists
NCT02006992 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which RTF Infant Formula is the first listed.
NCT02006992 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02006992 about?
NCT02006992 is a clinical study titled "Growth of Infants Fed Hydrolysate Formulas". Effects on weight and weight gain will be monitored in healthy term infants fed assigned infant formulas.
What is the current status of trial NCT02006992?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2000-03. Estimated completion is 2000-11.
What interventions are being tested in trial NCT02006992?
The interventions under investigation include: RTF Infant Formula (OTHER), Powder Infant Formula (OTHER).
Who is sponsoring clinical trial NCT02006992?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02006992's enrollment target sits among peer trials
195 567th of 2000 higher than 1,433 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia